Overall, an enhancement in the PC3-Pip tumor uptake in the presence of ACUPA ligands in the administered nanocarriers was observed with improved retention time, tissue penetration, and PC3-Pip/blood ratio, which may be employed in therapeutic applications. Here, PIP is linked to neoplasm.